Moderate to Vigorous Physical Activity and Chronic Rhinosinusitis Risk: A Longitudinal Fitbit Study
International Forum of Allergy & Rhinology · 2026
DOI: 10.1002/alr.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2026. Verfasst von Heli Majeethia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical and Computer Engineering, University of Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Rhinosinusitis, Exercise, Sinusitis, Rhinitis. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Introduction
Chronic rhinosinusitis (CRS) is an inflammatory condition of the sinonasal mucosa. While physical activity is known to modulate systemic inflammation, its role in CRS prevention remains unclear. This study evaluates the association between moderate to vigorous physical activity (MVPA) and CRS using longitudinal Fitbit data.
Methods
We conducted a retrospective cohort study within the All of Us Research Program using Fitbit‐derived activity data linked to electronic health records. Adults with ≥ 1 year of valid data were eligible. MVPA was averaged across “strict weeks” (7 valid days, > 100 steps/day) and categorized as < 75, 75–150, 150–225, 225–300, or > 300 min. CRS was defined using ICD‐10 coding. Propensity score matching was performed on demographics, obesity, and smoking status. Kaplan–Meier curves, Cochran–Mantel–Haenszel odds ratios, and fixed‐effects models assessed associations between MVPA and CRS.
Results
The matched cohort included 583 CRSsNP cases and 583 controls. Kaplan–Meier survival analysis demonstrated significant separation across MVPA groups ( p = 0.0099), with higher activity associated with lower cumulative incidence. Participants exercising 75–150 min/week had nearly twice the odds of CRS compared with those exercising 150–225 min (OR = 1.95, 95% CI 1.07–3.55). Timing models showed earlier diagnoses among the least active group (− 152 weeks, 95% CI − 169 to − 134) and later diagnoses among those exercising > 300 min/week (+ 260 weeks, 95% CI + 200 to + 320). Continuous modeling revealed an inverse dose‐response with a plateau beyond 300 min.
Conclusion
Regular MVPA is associated with reduced CRS incidence and prolonged disease‐free years, supporting physical activity as a possible modifiable risk factor for CRS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Electrical and Computer Engineering, University of Houston, Houston, Texas, USA.
- Texas A&M School of Engineering Medicine, Houston, Texas, USA.
- Department of Otolaryngology - Head and Neck Surgery, Houston Methodist Hospital, Houston, Texas, USA.
- Department of Information Science Technology, University of Houston, Houston, Texas, USA.
- Department of Otolaryngology - Head and Neck Surgery, Kaiser Permanente Orange County, CA, USA.
- Department of Otolaryngology - Head and Neck Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.
ORCID-Profile: Heli Majeethia, Aakash Agarwal, Masayoshi Takashima
Zitieren
APA
Majeethia, H., Agarwal, A., Abdou, A., Dwarampudi, J., Varghese, J., Hu, R., Mehdi, Z., Banerjee, T., Pandrangi, V., Wu, A., Tang, D., Takashima, M., & Ahmed, O. G. (2026). Moderate to Vigorous Physical Activity and Chronic Rhinosinusitis Risk: A Longitudinal Fitbit Study. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.70113
Vancouver
Majeethia H, Agarwal A, Abdou A, Dwarampudi J, Varghese J, Hu R, et al. Moderate to Vigorous Physical Activity and Chronic Rhinosinusitis Risk: A Longitudinal Fitbit Study. International Forum of Allergy & Rhinology. 2026. doi:10.1002/alr.70113
BibTeX
@article{Majeethia2026,
author = {Majeethia, Heli and Agarwal, Aakash and Abdou, Ahmed and Dwarampudi, Jagan and Varghese, Justina and Hu, Renjie and Mehdi, Zain and Banerjee, Tania and Pandrangi, Vivek and Wu, Arthur and Tang, Dennis and Takashima, Masayoshi and Ahmed, Omar G},
title = {Moderate to Vigorous Physical Activity and Chronic Rhinosinusitis Risk: A Longitudinal Fitbit Study},
journal = {International Forum of Allergy & Rhinology},
year = {2026},
doi = {10.1002/alr.70113}
}
EUVIMED